Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEXG vs PDXG in Advanced Pancreatic Cancer
NCT00966706Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jun 2005
- Primary completion
- Apr 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, epirubicin in pancreatic adenocarcinoma (PDAC), sponsored by IRCCS Ospedale San Raffaele. Started Jun 2005; status: completed.
02
Drugs
docetaxelepirubicin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00966706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966706.